{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-067005","form_type":"8-K","ticker":"TKNO","cik":"0001850902","company_name":"Alpha Teknova, Inc.","filed_at":"2025-05-08T23:59:59+00:00","discovered_at":"2026-05-14T18:02:50.149963+00:00","generated_at":"2026-05-22T05:30:45.125320+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.6,"confidence":"high","headline":"Teknova Q1 revenue up 5% to $9.8M, net loss narrows to $4.6M, guidance reaffirmed","bullets":["Q1 total revenue $9.8M (+5% YoY); Lab Essentials $8.1M (+12%), Clinical Solutions $1.2M (-32%).","Net loss narrowed to $4.6M ($0.09/share) from $8.1M ($0.20/share) in Q1 2024.","Adjusted EBITDA loss improved to $2.5M from $3.8M; free cash outflow decreased to $4.3M from $6.7M.","Exclusive collaboration with Pluristyx to manufacture/distribute PluriFreeze cryopreservation system in US/Canada.","Reaffirms FY2025 revenue guidance of $39-42M and free cash outflow under $12M."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-067005","json":"https://secwatch.observer/filing/0000950170-25-067005.json","markdown":"https://secwatch.observer/filing/0000950170-25-067005.md","text":"https://secwatch.observer/filing/0000950170-25-067005.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1850902/000095017025067005/0000950170-25-067005-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1850902/000095017025067005/tkno-20250508.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-22T05:30:45.125320+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}